MYBL2 and central nervous system cancer: Figure 2(c) showed the univariate Cox regression for MYBL2 and clinical factors. Multivariate Cox regression analysis indicated that MYBL2 and age might be independent prognostic biomarkers in gliomas (Figure 2(d)). To establish a more reliable prediction method in clinical practice, we constructed a nomogram integrating MYBL2 and age to predict 1-, 3-, and 5-year survival in glioma patients, and the calibration plot for patient survival prediction showed that the predicted results of the MYBL2 prognostic nomogram were in good agreement with the actual results (Figures 2(e) and 2(f)).